Article
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia
26 Aug 2025
Abstract excerpt
ABSTRACT: Acute myeloid leukemia (AML) is characterized by a low 5-year survival rate. Despite having many clinical metrics to assess patient prognosis, there remain opportunities to improve risk stratification. We hypothesized that an underexplored resource to examine the prognosis of patients with AML is plasma metabolome. Circulating metabolites are influenced by patients' clinical status and can serve as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
